Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Determining the Functional Role of RCOR1 in Diffuse Large B Cell Lymphoma
EF 2017-18
Résumé
Title: Determining the Functional Role of RCOR1 in Diffuse Large B Cell LymphomaDiffuse large B cell lymphoma (DLBCL) is an aggressive, fast growing cancer of B cells, the antibody-producing machinery of the immune system. Often associated with secondary sites of cancer growth in organs such as the digestive tract and bone marrow, DLBCL is one of the most common blood cancers with over 3000 new cases in Canada each year. While recent biomedical and technological advances in early diagnosis and treatment of the disease have improved, a major problem persists: about 30-40% of people living with DLBCL given chemotherapy are not cured or redevelop more severe ailment. The underlying causes of treatment failure are not well understood, but several studies have suggested that DNA mutations which affect the cellular expression of pro- and anti-cancer genes may be involved. The focus of my interests is restriction element 1-silencing transcription factor corepressor 1 ( RCOR1 ), a gene encoding a component of several DNA regulatory complexes. Because DNA structure ties in closely with the extent by which genes are expressed in cells, abnormalities in RCOR1 could result in dysfunctional cellular processes. Notably, work in our lab has demonstrated that DLBCL cases harboring RCOR1 mutations are strongly associated with poor outcome. Based on this knowledge, I believe it is imperative to improve our understanding of the role of RCOR1 in DLBCL as it may aid in identifying a subgroup of patients who require an alternative treatment method. Building on this foundation, novel therapies could be developed against DLBCL and potentially impact the lives of thousands of Canadians afflicted with the disease.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
386463
Name
Li Yu
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Determining the Functional Role of RCOR1 in Diffuse Large B Cell Lymphoma
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarkers; Cell Signaling; Diffuse Large B Cell Lymphoma; Drug Resistance; Epigenetic Mechanisms; Functional Assays; Lymphoma Pathogenesis; Molecular Biology; Mutations
Abstract
Title: Determining the Functional Role of RCOR1 in Diffuse Large B Cell LymphomaDiffuse large B cell lymphoma (DLBCL) is an aggressive, fast growing cancer of B cells, the antibody-producing machinery of the immune system. Often associated with secondary sites of cancer growth in organs such as the digestive tract and bone marrow, DLBCL is one of the most common blood cancers with over 3000 new cases in Canada each year. While recent biomedical and technological advances in early diagnosis and treatment of the disease have improved, a major problem persists: about 30-40% of people living with DLBCL given chemotherapy are not cured or redevelop more severe ailment. The underlying causes of treatment failure are not well understood, but several studies have suggested that DNA mutations which affect the cellular expression of pro- and anti-cancer genes may be involved. The focus of my interests is restriction element 1-silencing transcription factor corepressor 1 ( RCOR1 ), a gene encoding a component of several DNA regulatory complexes. Because DNA structure ties in closely with the extent by which genes are expressed in cells, abnormalities in RCOR1 could result in dysfunctional cellular processes. Notably, work in our lab has demonstrated that DLBCL cases harboring RCOR1 mutations are strongly associated with poor outcome. Based on this knowledge, I believe it is imperative to improve our understanding of the role of RCOR1 in DLBCL as it may aid in identifying a subgroup of patients who require an alternative treatment method. Building on this foundation, novel therapies could be developed against DLBCL and potentially impact the lives of thousands of Canadians afflicted with the disease.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Li, Yu
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~